8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

Labcorp ($LH) filed an 8‑K on Feb 9, 2026 furnishing a press release (Exhibit 99.1) and an Inline XBRL…

Filed with the SEC on February 9, 2026 · Summarized by InvestorsBot

Labcorp ($LH) filed an 8‑K on Feb 9, 2026 furnishing a press release (Exhibit 99.1) and an Inline XBRL cover page (Exhibit 104). Filing signed by Kathryn W. Kyle, EVP & Chief Legal Officer. 📰🗂️ #8K #SECfiling

Exhibits furnished — investors should review Exhibit 99.1 (press release) and Exhibit 104 (interactive XBRL) for any material updates from Labcorp. Filing date: Feb 9, 2026. $LH 🔎 #Labcorp #Healthcare

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from LABCORP HOLDINGS INC.

Labcorp ($LH) 8‑K: Term Loan Credit Agreement dated Mar 20, 2026 among Labcorp Holdings and lenders;…

8-K · March 20, 2026

LABCORP ($LH) 8-K filed 2026-03-20 — Item 2.03 states it incorporates Item 1.01 by reference re: creation…

8-K · March 20, 2026

BREAKING: Labcorp ($LH) CONFIRMED a $750M senior unsecured term loan — fully funded Mar 20, 2026; matures…

8-K · March 20, 2026

Labcorp filed an 8‑K on Feb 17, 2026: Exhibit 99.1 is a press release titled “Labcorp Announces 2025…

8-K · February 17, 2026

LabCorp ($LH) filed a Form 8‑K on Feb 17, 2026 reporting Item 2.02 — Results of Operations and Financial…

8-K · February 17, 2026

Labcorp ($LH) appointed Dr.

8-K · February 9, 2026